ProMIS Neurosciences Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -94.2% | -90.0% | +394.3% | -96.5% | +244.7% | +30.2% | +965.8% | -51.2% | -100.0% | – | – | |
| – | -4.0% | +76.0% | +98.6% | – | – | -32.8% | +83.8% | -99.7% | +69,209.6% | – | – | |
| – | – | – | +293.0% | -95.6% | -1,357,591.3% | – | – | – | – | – | – | |
| – | -40.1% | +81.7% | +127.0% | +72.7% | -13.0% | -32.8% | +55.5% | +324,947.4% | -100.0% | +34.9% | +213.8% | |
| – | -24.0% | +71.9% | +39.8% | +23.5% | +29.3% | -6.6% | +35.5% | +220,000.8% | -99.9% | -16.3% | +9.7% | |
| – | +33.8% | +142.3% | +87.0% | +55.9% | -0.9% | -66.5% | +86.7% | +504,553.2% | -100.0% | +99.1% | +138.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -33.8% | -64.5% | -100.0% | – | – | – | +67,657.3% | -99.9% | -61.9% | -100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | -1,529.3% | |
| – | +1,898,911.0% | -31.6% | -52.2% | -2,866.3% | – | – | +296,446,328.6% | -1,381.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -1,529.3% | |
| – | – | – | – | – | – | – | – | – | – | – | -1,490.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.